Ionis Pharmaceuticals(FRA) ISI

Market Cap€8.98B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€52.28

-1.58%

-0.84Today

Ionis Pharmaceuticals Financials at a Glance

Market Cap

€8.98B

Revenue (TTM)

€749.31

Net Income (TTM)

-€484.49

EPS (TTM)

-€2.98

P/E Ratio

-18.15

Dividend

€0.00

Beta (Volatility)

0.04 (Low)

Dividend

€0.00

Beta (Volatility)

0.04 (Low)

Price

€52.28

Volume

Open

€52.28

Price

€52.28

Volume

Open

€52.28

Previous Close

€52.28

Daily Range

€52.28 - €52.28

52-Week Range

€36.08 - €75.00

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.04 (Low)

Price

€52.28

Volume

Open

€52.28

Previous Close

€52.28

Daily Range

€52.28 - €52.28

52-Week Range

€36.08 - €75.00

Estimated Earnings Date

N/A

ISI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ionis Pharmaceuticals

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Industry

Biotechnology

Sector

Health Care

Employees

1,402

CEO

Brett P. Monia, PhD

Website

www.ionis.com

ISI Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-105.01%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-5.51%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€8.98B

Shares Outstanding

166.18M

Volume

Avg. Volume

71.379

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Ionis Pharmaceuticals Performance Analysis

Ionis Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 558,878,548	-18.5%
2023	2023-12-31	EUR 728,550,210	30.4%
2024	2024-12-31	EUR 651,885,020	-10.5%
2025	2025-12-31	EUR 836,194,788	28.3%

Ionis Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -1.81	954.4%
2023	2023-12-31	EUR -2.37	30.8%
2024	2024-12-31	EUR -2.81	18.6%
2025	2025-12-31	EUR -2.11	-24.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€230.45

+0.6%

Gross Profit

€221.53

+0.6%

Gross Margin

96.13%

+1.0%

Market Cap

€8.98B

N/A

Market Cap/Employee

€8.31

N/A

Employees

1,402

N/A

Net Income

-€98.60

-0.9%

EBITDA

-€81.41

-0.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€2.22K

+14.7%

Total Debt

€1.91K

+1.1%

Accounts Receivable

€51.47

+1.1%

Inventory

€44.46

+6.2%

Long Term Debt

€1.90K

+1.7%

Short Term Debt

€11.30

+0.0%

Return on Assets

-18.77%

+1.9%

Return on Invested Capital

-12.78%

+0.8%

Free Cash Flow

€468.24

+3.5%

Operating Cash Flow

€482.18

+3.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About ISI

What is the current price of Ionis Pharmaceuticals?

Ionis Pharmaceuticals is trading at €52.28 per share.

What is the 52-week range for Ionis Pharmaceuticals?

Over the past 52 weeks, Ionis Pharmaceuticals has traded between €36.08 and €75.00.

How much debt does Ionis Pharmaceuticals have?

As of the most recent reporting period, Ionis Pharmaceuticals reported total debt of €1.91B.

How much cash does Ionis Pharmaceuticals have on hand?

Ionis Pharmaceuticals reported €306.19M in cash and cash equivalents in its most recent financial results.

What is Ionis Pharmaceuticals’s dividend yield?

Ionis Pharmaceuticals does not currently have a dividend yield.

Ionis Pharmaceuticals(FRA) ISI

Ionis Pharmaceuticals Financials at a Glance

ISI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ionis Pharmaceuticals

ISI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ionis Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ISI

What is the current price of Ionis Pharmaceuticals?

What is the 52-week range for Ionis Pharmaceuticals?

How much debt does Ionis Pharmaceuticals have?

How much cash does Ionis Pharmaceuticals have on hand?

What is Ionis Pharmaceuticals’s dividend yield?

Premium Investing Services